Efficacy of Human Tendon-Derived Extracellular Matrix in Achilles Tendon Regeneration
Journal of Clinical Medicine · 17.06.2026 · 15 (12) · 4716
DOI: 10.3390/jcm15124716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.06.2026. Verfasst von Seong Kyeong Jo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Konyang University Hospital, Daejeon 35365, Republic of Korea. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HansBiomed Co., Ltd.
Abstract (Originalsprache)
Background/Objectives: Achilles tendon injuries exhibit slow and incomplete healing due to limited vascularity, cellularity, and a complex extracellular matrix (ECM). Biologically derived ECM-based therapies have emerged as promising strategies to enhance tendon repair by providing native biochemical cues. In this study, the efficacy of injectable human tendon-derived ECM (hT-ECM) was investigated using a rat Achilles tenotomy model.
Methods
Percutaneous tenotomy of the right Achilles tendon in 50 rats was performed. The animals were subjected to either no treatment as a control group (CON) or hT-ECM treatment group (ECM). Tendon healing was evaluated at 1 and 6 weeks using biomechanical, histological, transmission electron microscopy, Western blot, and immunohistochemical analysis.
Results
At 6 weeks, the ECM group exhibited higher load to failure (54.5 ± 15.0 N) than the CON group (28.6 ± 13.7 N) (p < 0.05). Histological evaluation revealed progressive restoration of the injured tendon in both groups over the healing period, with comparable results observed between the groups. Ultrastructural analysis revealed that the ECM group exhibited significantly increased collagen fibrils diameters (74.1 ± 19.1 nm) than the CON group (53.8 ± 13.8 nm) (p < 0.001). Western blot exhibited that collagen I (COL I) expression at 6 weeks was significantly higher in the ECM group compared with the CON group (p < 0.05).
Conclusions
These outcomes suggest that injectable hT-ECM improves early repair responses in a rat Achilles tenotomy model. Molecular analyses suggested that the therapeutic effects of hT-ECM injection could be linked to enhanced collagen type I production. Based on the study, hT-ECM injection might be a good adjuvant option for the treatment of Achilles tendon injuries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Konyang University Hospital, Daejeon 35365, Republic of Korea.
- Department of Clinical Pathology, Konyang University, Daejeon 35365, Republic of Korea.
- Department of Pathology, Wonkwang University Hospital, Iksan 54538, Republic of Korea.
- Advanced Medical Device R&D Center, HansBiomed Co., Ltd., Seoul 05836, Republic of Korea.
- Department of Pathology, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.
ORCID-Profile: Dae Hyung Lee, Yeji Choi, Jae Hwang Song
Förderung
- HansBiomed Co., Ltd
Zitieren
APA
Jo, S. K., Sakthiabirami, K., Gu, D. H., Lee, D. H., Choi, Y., Kim, D. Y., & Song, J. H. (2026). Efficacy of Human Tendon-Derived Extracellular Matrix in Achilles Tendon Regeneration. Journal of Clinical Medicine, 15(12), 4716. https://doi.org/10.3390/jcm15124716
Vancouver
Jo SK, Sakthiabirami K, Gu DH, Lee DH, Choi Y, Kim DY, et al. Efficacy of Human Tendon-Derived Extracellular Matrix in Achilles Tendon Regeneration. Journal of Clinical Medicine. 2026;15(12):4716. doi:10.3390/jcm15124716
BibTeX
@article{Jo2026,
author = {Jo, Seong Kyeong and Sakthiabirami, Kumaresan and Gu, Do Hyi and Lee, Dae Hyung and Choi, Yeji and Kim, Dae Young and Song, Jae Hwang},
title = {Efficacy of Human Tendon-Derived Extracellular Matrix in Achilles Tendon Regeneration},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4716},
doi = {10.3390/jcm15124716}
}
EUVIMED